TrueBlue - TBI Stock Forecast, Price & News

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" TBI shares.
View TBI analyst ratings or view top-rated stocks.

2 brokers have issued 1-year price targets for TrueBlue's shares. Their TBI share price forecasts range from $20.00 to $21.00. On average, they anticipate the company's share price to reach $20.50 in the next twelve months. This suggests that the stock has a possible downside of 0.6%.
View analysts price targets for TBI or view top-rated stocks among Wall Street analysts.

TrueBlue's stock was trading at $27.67 at the beginning of the year. Since then, TBI stock has decreased by 25.5% and is now trading at $20.62.
View the best growth stocks for 2022 here.

TrueBlue saw a drop in short interest in the month of November. As of November 15th, there was short interest totaling 461,800 shares, a drop of 25.2% from the October 31st total of 617,100 shares. Based on an average daily trading volume, of 154,800 shares, the days-to-cover ratio is presently 3.0 days. Currently, 1.5% of the shares of the company are short sold.
View TrueBlue's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our TBI earnings forecast.

TrueBlue, Inc. (NYSE:TBI) issued its quarterly earnings results on Monday, October, 24th. The business services provider reported $0.75 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.75. The business services provider had revenue of $575.72 million for the quarter, compared to the consensus estimate of $587.22 million. TrueBlue had a trailing twelve-month return on equity of 19.17% and a net margin of 3.25%. The firm's quarterly revenue was down .2% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.59 EPS.

TrueBlue updated its fourth quarter 2022 earnings guidance on Tuesday, November, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $550.00 million-$575.00 million, compared to the consensus revenue estimate of $592.23 million.

34 employees have rated TrueBlue Chief Executive Officer Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among the company's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

TrueBlue's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (16.56%), Vanguard Group Inc. (12.93%), Dimensional Fund Advisors LP (7.63%), Pzena Investment Management LLC (6.82%), State Street Corp (3.78%) and Royce & Associates LP (1.23%). Insiders that own company stock include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, Garrett Ferencz, Richard Christensen, Steven C Cooper, Taryn R Owen and William C Goings.
View institutional ownership trends.

Shares of TBI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TBI stock can currently be purchased for approximately $20.62.

TrueBlue (NYSE:TBI) has a market capitalization of $674.69 million and generates $2.17 billion in revenue each year. The business services provider earns $61.63 million in net income (profit) each year or $2.22 on an earnings per share basis.

The company employs 6,400 workers across the globe.

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The official website for the company is www.trueblue.com. The business services provider can be reached via phone at (253) 383-9101, via email at investorrelations@trueblueinc.com, or via fax at 877-733-0399.